‘First probable case of Monkeypox in West Virginia’ -WTRF.com Report
https://www.wtrf.com/west-virginia/first-probable-case-of-monkeypox-in-west-virginia/?utm_medium=referral&utm_campaign=socialflow&utm_source=t.co
AbbVie Dumps An Early-Alzheimer’s Candidate Developing In Collaboration With Alector
AbbVie Inc (NYSE:ABBV) has decided to terminate the CD33 collaboration program with Alector Inc (NASDAQ:ALEC), developing AL003 for Alzheimer’s disease as one of…
‘First cases of monkeypox confirmed in South Carolina’ -News19 Report
https://www.wltx.com/article/news/health/confirmed-first-cases-of-monkeypox-in-south-carolina-midlands-lowcountry-dhec/101-710eb9a5-4f1c-44d0-9b35-0a59923a70f7
Horizon Therapeutics Receives FDA Approval For Uncontrolled Gout Candidate
The U.S. Food and Drug Administration (FDA) has approved Horizon Therapeutics’ (NASDAQ: HZNP) supplemental Biologics License Application (sBLA) for expanding the labeling to include KRYSTEXXA (pegloticase) injection co-administered with methotrexate, in patients with uncontrolled gout.
The Daily Biotech Pulse: Pfizer Inks Pact With Africa For COVID-19 Pills, Emergent Bio & Ridgeback To Increase Access To Ebola Treatment, ADC Therapeutics & Sobi In European Pact For Lymphoma Drug
Here's a roundup of top developments in the biotech space over the last 24 hours:
ADC Therapeutics, Sobi Ink European Licensing Pact For Lymphoma Drug
ADC Therapeutics SA (NYSE:ADCT) has entered into an exclusive license agreement with Swedish Orphan Biovitrum AB (OTC:BIOVF) for the development and commercialization of…
Optinose Announces Additional Results From ReOpen2 And Initial Results From Pooled Analyses Of Both Trials In The ReOpen Program
Company previously announced positive top-line results from both ReOpen1 and ReOpen2, the landmark trials evaluating XHANCE as a treatment for chronic sinusitis
Multiple secondary endpoints from ReOpen2 indicate
RVL Pharma Issues Interim Q2 Sales From Its Droopy Eye Treatment
RVL Pharmaceuticals plc (NASDAQ:RVLP) announced preliminary Q2 FY22 sales from Upneeq of $8.4 million, up 42% sequentially. Upneeq (oxymetazoline hydrochloride…